Release Date: 27/04/17 16:58 Summary: March Quarterly Activities Report Price Sensitive: Yes Download Document 1.46MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%